![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Thursday, June 08, 2017 4:43:08 PM
Dr. Bosch mentioned a time frame that puts the last patient enrolled in the earliest part of November 2015 based on a June 5th presentation point of referrence. The 66th PFS event was announced in December 2013. The midpoint of trial enrollment occurred in May 2014. The enrollment rate then was about the lower mid twenties per quarter if I recall correctly. So ~167-~41=~126 enrolled at the end of 2013. Someone may be able to correct me on this if they have a screen shot of the enrollment chart Dr. Bosch recently shared. If there is no corrrction, this means 66 PFS events occurred out of ~126 patients enrolled between 2008 and 2013 with most having enrolled from the beginning of 2012 forward. A median enrollment month for this group most likely would have been in October 2012 or in a month on either side of it with late September to mid November being most likely. October 2012 to early December 2013 is roughly 13-13.5 months depending on exact dates. This then is rougly the median blended group PFS eventing time. This event time was also one being reported multiple times annectdotally on this message board based on public patient accounts. Dr. Bosch, in his recent presentation, reiterated the standard SOC event rates and suggested once again that these have not changed much. These rates are much lower than 13 months. We can not put much into this as his duty is to tow the company line but he did not suggest anything unusual had been seen in trial PFS event rates while he did note that OS rates were slower than anticipated. Trial enrollment criteria may help SOC in the early part of the trial while later lowered absolute lymphocyte count for patients in Germany probably helped neutralize that advantage to a small degree at the end. A 13-13.5 mixed PFS is probably too close to call once factoring in potential early SOC trial inclusion criteria so going to observed trial strength and allowing PFS data to strengthen before unblinding it and OS makes sense. I really like what sentiment_stocks recently wrote about PFS but I always like to keep in mind the weakest link. Best wishes.
Recent NWBO News
- Biophma Announces Exclusive In License for Dendritic Cell Technology, Sending Shares Higher • AllPennyStocks.com • 06/17/2024 04:40:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/04/2024 09:11:16 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 06/03/2024 09:22:55 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 05/22/2024 08:13:36 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/10/2024 09:04:57 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/01/2024 10:04:38 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/02/2023 01:31:35 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/16/2023 10:11:54 PM
- Epazz, Inc. (OTC Pink: EPAZ) ZenaDrone Demonstration to Defense Departments of UAE and Saudi Arabia • InvestorsHub NewsWire • 11/15/2023 12:19:31 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/09/2023 09:30:39 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 • InvestorsHub NewsWire • 11/09/2023 01:00:34 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 Extreme Weather Demo • InvestorsHub NewsWire • 11/07/2023 12:29:43 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/09/2023 08:36:14 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM
North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM
Branded Legacy, Inc. and Hemp Emu Announce Strategic Partnership to Enhance CBD Product Manufacturing • BLEG • Jun 27, 2024 8:30 AM
POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • POET • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM